(S)-amphetamine increases expression ISO RGD:731346 6480464 Dextroamphetamine results in increased expression of IDO1 protein CTD PMID:31760073 (S)-amphetamine multiple interactions ISO RGD:731346 6480464 [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Dextroamphetamine results in increased expression of IDO1 protein] more ... CTD PMID:31760073 1,2-dimethylhydrazine decreases expression ISO RGD:731346 6480464 1, 2-Dimethylhydrazine results in decreased expression of IDO1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:731346 6480464 Estradiol results in increased expression of IDO1 mRNA, Estradiol results in increased expression of INDO mRNA CTD PMID:18367319 , PMID:19484750 17beta-estradiol multiple interactions ISO RGD:731346 6480464 bazedoxifene inhibits the reaction [Estradiol results in increased expression of IDO1 mRNA] more ... CTD PMID:18367319 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731346 6480464 [[Lipopolysaccharides binds to and results in increased activity of TLR4 protein] which co-treated with Tetrachlorodibenzodioxin] results in increased expression of IDO1 mRNA CTD PMID:21097750 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731346 6480464 Tetrachlorodibenzodioxin results in increased expression of IDO1 mRNA CTD PMID:18694728 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IDO1 mRNA CTD PMID:18694728 , PMID:27783115 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IDO1 mRNA] CTD PMID:18694728 2,4,6-tribromophenol decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:731346 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IDO1 mRNA CTD PMID:17982090 3',5'-cyclic AMP multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 mRNA] more ... CTD PMID:32781018 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of IDO1 protein CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:731346 6480464 tetrabromobisphenol A results in decreased expression of IDO1 protein CTD PMID:35343813 3,3',5,5'-tetrabromobisphenol A increases methylation ISO RGD:731346 6480464 tetrabromobisphenol A results in increased methylation of IDO1 gene CTD PMID:35343813 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of IDO1 mRNA CTD PMID:23300844 acetylsalicylic acid affects response to substance EXP 6480464 IDO1 affects the susceptibility to Aspirin CTD PMID:19489917 acyclovir decreases activity EXP 6480464 Acyclovir results in decreased activity of IDO1 protein CTD PMID:17174341 ammonium chloride affects expression ISO RGD:619989 6480464 Ammonium Chloride affects the expression of IDO1 mRNA CTD PMID:16483693 anthranilic acid decreases abundance ISO RGD:731346 6480464 IDO1 gene mutant form results in decreased abundance of anthranilic acid CTD PMID:32871117 arsenite(3-) decreases methylation EXP 6480464 arsenite results in decreased methylation of INDO promoter CTD PMID:23974009 atrazine affects methylation ISO RGD:619989 6480464 Atrazine affects the methylation of IDO1 gene CTD PMID:28931070 bazedoxifene multiple interactions ISO RGD:731346 6480464 bazedoxifene inhibits the reaction [Estradiol results in increased expression of IDO1 mRNA] CTD PMID:18367319 belinostat multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IDO1 mRNA CTD PMID:27188386 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of IDO1 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of IDO1 promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of IDO1 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:619989 6480464 bisphenol A results in decreased expression of IDO1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:731346 6480464 bisphenol A results in decreased expression of IDO1 protein CTD PMID:35343813 bisphenol A increases methylation ISO RGD:731346 6480464 bisphenol A results in increased methylation of IDO1 gene CTD PMID:35343813 bisphenol A increases methylation ISO RGD:619989 6480464 bisphenol A results in increased methylation of IDO1 gene CTD PMID:28505145 buta-1,3-diene decreases expression ISO RGD:731346 6480464 1, 3-butadiene results in decreased expression of IDO1 mRNA CTD PMID:29038090 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of IDO1 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:619989 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IDO1 protein CTD PMID:35489423 cadmium dichloride increases methylation ISO RGD:619989 6480464 Cadmium Chloride results in increased methylation of IDO1 promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:619989 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IDO1 protein CTD PMID:35489423 cannabidiol multiple interactions EXP 6480464 AM 281 promotes the reaction [Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein]] more ... CTD PMID:19167098 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of IDO1 mRNA CTD PMID:29348435 chromium(6+) affects expression ISO RGD:731346 6480464 chromium hexavalent ion affects the expression of IDO1 mRNA CTD PMID:28472532 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of IDO1 mRNA CTD PMID:23300844 cisplatin multiple interactions EXP 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of IDO1 mRNA CTD PMID:30871063 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of IDO1 mRNA CTD PMID:27392435 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of IDO1 mRNA CTD PMID:18348204 cyclophosphamide multiple interactions ISO RGD:619989 6480464 Quercetin inhibits the reaction [Cyclophosphamide results in increased expression of IDO1 protein] CTD PMID:34748891 cyclophosphamide increases expression ISO RGD:619989 6480464 Cyclophosphamide results in increased expression of IDO1 protein CTD PMID:34748891 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of IDO1 protein CTD PMID:31675489 dextran sulfate increases expression ISO RGD:731346 6480464 Dextran Sulfate results in increased expression of IDO1 mRNA CTD PMID:23894361 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression EXP 6480464 entinostat results in increased expression of IDO1 mRNA CTD PMID:26272509 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IDO1 mRNA CTD PMID:27188386 gadodiamide hydrate increases expression EXP 6480464 gadodiamide results in increased expression of IDO1 mRNA CTD PMID:20959327 hyaluronic acid multiple interactions ISO RGD:619989 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDO1 protein] CTD PMID:23178681 hyaluronic acid decreases expression ISO RGD:619989 6480464 Hyaluronic Acid analog results in decreased expression of IDO1 protein CTD PMID:23178681 hydrogen peroxide multiple interactions ISO RGD:619989 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDO1 protein] CTD PMID:23178681 hydrogen peroxide decreases expression ISO RGD:619989 6480464 Hydrogen Peroxide results in decreased expression of IDO1 protein CTD PMID:23178681 indirubin-3'-monoxime increases expression ISO RGD:731346 6480464 indirubin-3'-monoxime results in increased expression of IDO1 protein CTD PMID:21948866 indirubin-3'-monoxime multiple interactions ISO RGD:731346 6480464 Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of IDO1 protein] CTD PMID:21948866 indole-3-methanol increases expression ISO RGD:731346 6480464 indole-3-carbinol results in increased expression of IDO1 mRNA CTD PMID:21948866 indole-3-methanol multiple interactions ISO RGD:731346 6480464 Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of IDO1 mRNA] CTD PMID:21948866 kynurenine decreases abundance ISO RGD:731346 6480464 IDO1 gene mutant form results in decreased abundance of Kynurenine CTD PMID:32871117 L-tryptophan increases abundance ISO RGD:731346 6480464 IDO1 gene mutant form results in increased abundance of Tryptophan CTD PMID:32871117 L-tryptophan increases expression EXP 6480464 Tryptophan results in increased expression of IDO1 protein CTD PMID:32781018 lasofoxifene increases expression ISO RGD:731346 6480464 Lasofoxifene results in increased expression of IDO1 mRNA CTD PMID:18367319 lasofoxifene multiple interactions ISO RGD:731346 6480464 Lasofoxifene inhibits the reaction [Estradiol results in increased expression of IDO1 mRNA] CTD PMID:18367319 lead diacetate increases expression ISO RGD:731346 6480464 lead acetate results in increased expression of IDO1 mRNA CTD PMID:20542052 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of IDO1 mRNA CTD PMID:20884048 more ... lipopolysaccharide increases expression ISO RGD:731346 6480464 Lipopolysaccharides results in increased expression of IDO1 mRNA CTD PMID:33038329 lipopolysaccharide increases activity ISO RGD:731346 39939031 Lipopolysaccharide increases activity of Ido1 protein in splenic conventional dendritic cell RGD lipopolysaccharide multiple interactions EXP 11528429 lipopolysaccharide increases activity and expression of IDO1 protein in Langerhans cell-like dendritic cells RGD lipopolysaccharide multiple interactions ISO RGD:731346 6480464 3-(4-chlorophenylselanyl)-1-methyl-1H-indole inhibits the reaction [Lipopolysaccharides results in increased expression of IDO1 mRNA] more ... CTD PMID:21097750 more ... lipopolysaccharide multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:20884048 , PMID:35811015 lithium atom multiple interactions ISO RGD:731346 6480464 [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Dextroamphetamine results in increased expression of IDO1 protein] CTD PMID:31760073 lithium chloride multiple interactions ISO RGD:731346 6480464 [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Dextroamphetamine results in increased expression of IDO1 protein] CTD PMID:31760073 lithium hydride multiple interactions ISO RGD:731346 6480464 [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Dextroamphetamine results in increased expression of IDO1 protein] CTD PMID:31760073 medroxyprogesterone acetate multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 mRNA] more ... CTD PMID:32781018 muramyl dipeptide increases expression ISO RGD:731346 39938959 muramyl dipeptide increases expression of Ido1 mRNA in peritoneal macrophages and splenocytes RGD N-nitrosodiethylamine multiple interactions ISO RGD:619989 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of IDO1 mRNA CTD PMID:20360939 neopterin multiple interactions EXP 6480464 [Plant Preparations results in increased activity of IDO1 protein] which results in increased abundance of Neopterin more ... CTD PMID:19167098 nickel atom increases expression EXP 6480464 Nickel results in increased expression of IDO1 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of IDO1 mRNA CTD PMID:16780908 nitric oxide multiple interactions EXP 6480464 Nitric Oxide binds to and affects the folding of and results in increased degradation of and results in decreased activity of IDO1 protein CTD PMID:16834326 nitroglycerin decreases expression ISO RGD:619989 6480464 Nitroglycerin results in decreased expression of IDO1 protein CTD PMID:28659861 ozone multiple interactions ISO RGD:731346 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IDO1 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:731346 6480464 Acetaminophen affects the expression of IDO1 mRNA CTD PMID:17562736 perfluorododecanoic acid increases expression ISO RGD:619989 6480464 perfluorododecanoic acid results in increased expression of IDO1 protein CTD PMID:19854247 phenethyl caffeate multiple interactions ISO RGD:619989 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of IDO1 mRNA CTD PMID:20360939 PhIP increases expression ISO RGD:619989 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of IDO1 mRNA CTD PMID:33945839 pirinixic acid multiple interactions ISO RGD:731346 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of IDO1 mRNA] CTD PMID:17950772 pirinixic acid decreases expression ISO RGD:731346 6480464 pirinixic acid results in decreased expression of IDO1 mRNA CTD PMID:17426115 , PMID:17950772 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of IDO1 mRNA CTD PMID:27783115 poly(I:C) multiple interactions EXP 11528429 poly(I:C) co-treated with tryptophan or alone increases activity and expression of IDO1 protein in Langerhans cell-like dendritic cells RGD quercetin increases expression EXP 6480464 Quercetin results in increased expression of IDO1 protein CTD PMID:15221776 quercetin multiple interactions ISO RGD:619989 6480464 Quercetin inhibits the reaction [Cyclophosphamide results in increased expression of IDO1 protein] CTD PMID:34748891 raloxifene increases expression ISO RGD:731346 6480464 Raloxifene Hydrochloride results in increased expression of IDO1 mRNA CTD PMID:18367319 raloxifene multiple interactions ISO RGD:731346 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of IDO1 mRNA] CTD PMID:18367319 resveratrol affects activity EXP 6480464 resveratrol affects the activity of IDO1 protein CTD PMID:16154495 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:35811015 Salinomycin multiple interactions EXP 6480464 salinomycin binds to and results in decreased activity of IDO1 protein more ... CTD PMID:32822738 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of IDO1 CTD PMID:20491794 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Lipopolysaccharides results in increased expression of IDO1 mRNA] CTD PMID:20884048 temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of IDO1 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:731346 6480464 Testosterone results in increased expression of IDO1 mRNA CTD PMID:19693291 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of IDO1 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:731346 6480464 Carbon Tetrachloride results in increased expression of IDO1 mRNA, Carbon Tetrachloride results in increased expression of IDO1 protein CTD PMID:32289347 tetrachloromethane increases expression ISO RGD:731346 39939037 tetrachloromethane increases expression of Ido1 protein in serum RGD trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of IDO1 mRNA CTD PMID:24935251 trimellitic anhydride affects expression ISO RGD:731346 6480464 trimellitic anhydride affects the expression of IDO1 mRNA CTD PMID:19042947 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of IDO1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:731346 6480464 Valproic Acid inhibits the reaction [Dextroamphetamine results in increased expression of IDO1 protein] CTD PMID:31760073 vinclozolin decreases methylation ISO RGD:619989 6480464 vinclozolin results in decreased methylation of IDO1 gene CTD PMID:31079544 XL147 multiple interactions ISO RGD:731346 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of IDO1 mRNA CTD PMID:27935865 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of INDO mRNA CTD PMID:18316168 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of INDO mRNA CTD PMID:18316168 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of IDO1 mRNA, zoledronic acid results in increased expression of INDO mRNA CTD PMID:24714768